Clinical trial
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic…
NCT00287131 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00287131 |
|---|---|
| Title | Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients |
| Official title | Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Procedure |
| Interventions | Procedure - Adoptive cell transfer |
| Enrollment | 70 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Nov 1, 2013 |
| First posted | Feb 6, 2006 |
| Last update posted | Mar 29, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: